Project Grant R01CA311048
Award Date 5/13/26
Completion Date 4/30/31
Dollars Obligated $681K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Houston, TX 77030, USA
Similar Awards
- Federal Grant Award Summary Baylor College of Medicine received a $160,000 Project Grant from the National Cancer Institute (NCI) under the Cancer Biology Research program (CFDA 93.396), awarded May 1, 2026, with completion targeted for April 30, 2028. The grant funds research aimed at dissecting the metabolic rewiring mediated by SMARCB1 (Switch/Sucrose Non-Fermentable-related, Matrix-associated, Actin-dependent Regulator of Chromatin, Subfamily B, Member 1) loss in metastatic bladder cancer....
- Federal Grant Award Summary Baylor University received a $545,000 Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) effective May 1, 2026, through April 30, 2029. The award supports fundamental research investigating tumor cell autonomous and non-autonomous mechanisms of Lipocalin-2 (LCN2) function in solid tumor metastasis. The research will employ single-cell spatial proteomic and transcriptomic analyses to determine how LCN2...
- Federal Grant Award Summary Baylor College of Medicine received a $160,500 Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396), effective July 10, 2025, with completion targeted for June 30, 2027. The award funds the development and investigation of in vivo murine models to examine the role of caspase-2 in nucleophosmin-mutated acute myeloid leukemia (NPM1C+ AML). The research deliverables include the establishment of transgenic mouse...
- Federal Project Grant Award Summary Baylor College of Medicine received a $411,404 Project Grant from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) awarded on August 20, 2025, with a completion date of July 31, 2027. This research initiative aims to identify genes with a significant deficit of loss-of-function (LOF) mutations in lung tumors, a novel approach to cancer-related gene identification. The project utilizes statistical regression modeling and...
- Federal Grant Award Summary Health Research, Inc. (Roswell Park Division) received a $639,379 Project Grant from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396) effective May 1, 2026, through April 30, 2031. The award supports the development and validation of neuroendocrine bladder carcinoma (NEBC) models to advance translational cancer research in response to PAR-24-306. The project addresses a critical unmet clinical need by developing complementary...
- Federal Grant Award Summary Baylor College of Medicine received $882,470 in funding from the National Cancer Institute (NCI) under the Cancer Treatment Research program (CFDA 93.395) for a five-year project period beginning September 1, 2025, and concluding August 31, 2030. Under this NCI Research Specialist (Clinician Scientist) Award, the institution will deliver clinical trial leadership and research coordination services focused on pediatric and adolescent cancer care, particularly for...
- Federal Grant Award Summary Baylor College of Medicine received a $2.4 million Project Grant award from the National Cancer Institute under the Cancer Biology Research program (CFDA 93.396), effective August 15, 2025 through July 31, 2029. The award funds research investigating the role of RNA sequestration in acute myeloid leukemia (AML), specifically examining how the RNA helicase DDX6 (DEAD-Box Helicase 6) regulates post-transcriptional processes critical to leukemia development and...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded The Institute For Cancer Research a Project Grant totaling $766,439 (awarded April 1, 2026, with completion targeted for March 31, 2031) under the Cancer Cause and Prevention Research program (CFDA 93.393). This research project focuses on intratumor heterogeneity as a correlate of clinical outcomes in bladder cancer patients seeking to avoid radical cystectomy. The research addresses the critical clinical need for...
- Federal Project Grant Award Summary Baylor University received a $300,002 Project Grant from the National Cancer Institute under the Cancer Detection and Diagnosis Research Program (CFDA 93.394), awarded September 4, 2025, with a completion date of August 31, 2029. The project titled "Graph-String Transformer and Reinforcement Learning for Design of Cancer Theranostics" aims to develop an artificial intelligence (AI)-driven approach for accelerating the discovery of dual-targeted...
- Federal Grant Award Summary The National Cancer Institute awarded The Institute For Cancer Research a $483,395 Project Grant under the Cancer Treatment Research program (CFDA 93.395) beginning September 1, 2025, and concluding August 31, 2027. This research initiative focuses on investigating P300 and CBP (Cyclic AMP-Response Element Binding Protein) as novel therapeutic targets in renal cell carcinoma (RCC), specifically clear cell RCC (ccRCC). The project will examine the therapeutic potential...